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Abstract

The need for quality end-of-life care has increased drastically around the world in the last
few centuries due to a surge in life expectancy. As people are living much longer, they are
developing and succumbing to chronic progressive diseases which can significantly decrease
quality of life. But what exactly does it mean to care for the aging population who are nearing
death? Defining quality care at the end-of-life is important but also differs for individuals based
on a variety of factors including age, culture, and life experiences. End-of-life care does not
come as “one size fits all” and it challenges our healthcare system to design flexible treatment
plans aimed to achieve a good death. When considering what is important to individuals during
end-of-life, we must consider factors contributed by patients and their families but also by
physicians and other care providers (nurses, chaplain, social workers). Therefore, the purpose of
this literature analysis is to explore specific factors of treatment which need to be considered in
order to improve end-of-life care as well as focus on the core elements necessary to provide
individuals with a dignified death.
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Introduction

“You matter because you are you, and you matter to the end of your life. We will do all we can
not only to help you die peacefully, but also to live until you die.”
-Dr. Cicely Saunders, founder of the modern hospice movement, 1959
End-of-life care has become one of the most challenging issues in healthcare. There is a
significant need for improving end-of-life care due to a surge in life expectancy. Between 1959
and 2016, life expectancy in the United States has increased from 69.9 years to 78.9 (Woolf,
2019). The majority of the population is no longer dying due to acute infectious diseases, such as
pneumonia or tuberculosis, but rather chronic diseases that bring about a prolonged dying
process, such as cardiovascular disease or malignant neoplasms (Heron, 2017). Notably, life
expectancy has been seen to decrease with each additional chronic condition. For example, A 67year-old individual with no chronic conditions will live on average 22.6 additional years, but a
67-year-old individual with five chronic conditions and 10 or more chronic conditions will live
7.7 fewer years and 17.6 fewer years, respectively (DuGoff, 2014). Advancements in medicine
have made treating these seriously ill patients possible in order to extend life but have brought up
questions whether unnecessarily prolonging life is an appropriate goal of treatment. There is
increasing acknowledgment that other goals that should instead guide end-of-life decision
making. More patients have shown preference for treatment focused on relieving pain and
discomfort whereas a small minority has shown preference for life-extending treatment (Mack,
2010). Defining quality care at the end-of-life is important but also differs for individuals based
on a variety of factors including age, culture, and life experiences. End-of-life care does not
come as “one size fits all” and it challenges our healthcare system to design flexible treatment
plans aimed to achieve a good death. When considering what is important to individuals during
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end-of-life, we must consider factors contributed by patients and their families but also by
physicians and other care providers (nurses, chaplain, social workers). These goals of treatment
are influenced by many parties, including patients themselves, their families, and care teams, but
also encompass different aspects of social, psychological, and spiritual support.
Review of Literature
To begin this review, it is necessary to understand that Americans are very diverse and
discussing end-of-life preferences can vary greatly from one person to the next. Particular factors
which have been mentioned in previous research are not standards for end-of-life care but rather
suggestions that policy and health care systems can be built on. The details of advanced care
planning and treatments offered for patients near end-of-life and their families are their own
preferences which they decide on. This review will aim to cover the most common and
significant factors which have been previously studied, including factors of treatment, advanced
care planning, costs of treatment, palliative and hospice care, and education, as well as explore
the implications of the recent pandemic caused by SARS-CoV-2 on end-of-life care. Death is a
complex subject and can be interpreted in different ways, but the common denominator in every
story is that the terminally ill patient deserves to have options available in order to achieve the
death they wish for.
Factors of Treatment
Practice of medicine is being challenged by the increasing number of Americans with
varying combinations of frailty, functional limitations, physical and cognitive decline, and
multiple chronic diseases. Many of these patients who are near end-of-life have expressed fear of
experiencing great pain due to their complex disabilities. In 1986, the World Health Organization
declared undertreatment of pain to be a public health crisis (WHO, 1986). Since then, numerous
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guidelines and interventions have been released and tested. Pain is a common symptom of endof-life and is reported to occur in approximately 50% of patients in the last month of life
(Institute of Medicine, 2015). Pain experienced by terminally ill patients is often treated with
medications which alleviate signs and symptoms of pain but are controversial when they hasten
death. Specifically, there is concern that use of opioids can hasten death, and this may be the
reason that pain is poorly managed in terminally ill patients. However, studies have shown that
death in end-of-life patients is influenced by many factors and concern about hastening death or
compromising respiratory status does not justify withholding opioid use (Portenoy, 2006).
Opiates are the medication of choice for pain control and dyspnea, or difficulty breathing, which
are common symptoms of active death (Albert, 2017).
Dyspnea can be caused by many different mechanisms, including aspiration pneumonia,
pulmonary edema, heart failure, pleural effusions, and deconditioning. It is often hard to assess
dyspnea in end-of-life patients because it requires the patient to report specific signs and
symptoms of difficulty breathing. Clinical assessments done by care teams can look for
tachypnea, labored respirations, restlessness, and grunting as signs (Albert, 2017). Other
symptoms frequently treated with medications in end-of-life include anxiety, delirium, increased
oral secretions, nausea and vomiting. Benzodiazepines, such as lorazepam and midazolam, have
potentially sedating effects but have also been effective at treating anxiety in the last hours to
days of life (Henderson, 2006). As the ability to swallow is diminished and patients have
difficulties with swallowing pills, medications are typically administered sublingually,
transdermally, or via rectal suppository. Effective and proper management of symptoms at the
end-of-life can be challenging but is often achieved with only a few medications. Clinicians are
tasked with helping these patients and their families through the process of end-of-life by

END-OF-LIFE CARE

5

appropriately dosing and administering these medications with the assurance that it will be safe
and as comfortable as possible.
The Study to Understand Prognosis and Preferences for Outcomes and Risks of
Treatments (SUPPORT) documented that many patients receive unwanted, invasive, and
expensive care and experience prolonged and painful deaths (Murphy, 2000). Avoiding
unwanted pain may also include forgoing aggressive treatments which provide little hope for
meaningful recovery. End-of-life conversations between patients and physicians are associated
with fewer life-sustaining procedures and lower rate of intensive care unit admission (Wright,
2005). Some terminally ill patients decline resuscitation and intubation due to significant pain
and unlikelihood of surviving these aggressive measures of sustaining life.
In contrast, studies have shown that African Americans are more likely than Whites to
want aggressive care at the end-of-life, hold less favorable beliefs about hospice due to distrust in
the healthcare system, and hold beliefs that conflict with the goals of palliative care (Johnson,
2008). Almost 50% of Caucasians who died in 2016 used hospice care compared to 31% to 37%
of those with African American, Asian, or Native American descent (Bhatnagar, 2021). Ethnicity
can be a sign of common cultural beliefs and values that can impact end-of-life decisions but is
not a definite indication of one preference of treatment over another. Providing culturally
sensitive end-of-life care becomes more important as the diversity of America grows.
Terminal illness can impact not only physical health but also mental and spiritual
wellbeing. Meeting the spiritual and psychological needs near end-of-life are especially
important when physical healing is no longer possible. Inclusion of chaplaincy services is
significantly associated with lower rates of hospital deaths and higher rates of hospice enrollment
(Flannelly, 2012). In this case, a chaplain can provide assistance to the patient and family
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members in making decisions on end-of-life care and whether their values and wishes would
align with possible treatment plans. The importance of psychological and social professionals in
helping patients and their families through the aging and dying process is now more widely
accepted. Medication side effects, physical impairments, dependency, bereavement, and family
dysfunction frequently can occur, even simultaneously, during a terminal illness and can increase
the risk of psychological and psychiatric difficulties. Although more health care professionals are
aware of the impact of end-of-life and diagnosis of terminal illness on psychological being
(Karel, 2012), it can be hard to assess psychological changes in a patient near end-of-life because
it is sometimes assumed that increased dysphoric mood, anxiety, or suicidal ideation is normal
for those who have accepted or come to terms with their death quickly approaching. Providing
proper training and resources to care teams and family members can help with providing support
to terminal patients who are undergoing psychological changes.
Considering the patient as an individual with specific preferences for care is important
when determining end-of-life care. One person may want aggressive measures in order to have
more time with family and friends while another individual may want to be freed immediately
from their chronic and progressive diseases. Some patients will want spiritual, psychological,
and/or social activities to be incorporated into their end-of-life care. As end-of-life approaches,
healthcare and medical decisions should ideally include balanced medical, ethical, psychosocial,
and societal considerations.
Advance Care Planning
Recognizing that end-of-life is near can be particularly difficult for patients and is often
ignored even if recognized. Many people nearing the end-of-life are unable to cognitively or
physically make their own decisions about the care they wish to receive and often rely on a
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designated family member or close friend to make these decisions for them. Even when these
family members or friends are confident in the dying person’s wishes, it can still be emotionally
difficult for them to move forward with these decisions. Studies have shown that the treatments
patients would prefer at the end-of-life are often different from the treatments they actually
receive (Fried, 2002). Advance care planning ensures that a patient’s wishes can be respected
when their physical or cognitive decline begins.
An advance directive is a legal document used to appoint these medical decisions.
However, only one in three Americans completes any type of advance directive for end-of-life
care (Yadav, 2017). Many individuals who do participate in advance care planning prioritize
their independence and quality of life over quantity of life (Institute of Medicine, 2015). Having
a set plan in place also reduces the deep regret and guilt family members or friends may develop
while trying to make complex end-of-life decisions for someone. While there is no current
standard procedure in medicine which outlines exactly when, how, or who should initiate
advance care planning, these are conversations which should be encouraged and documented by
both patients and professional caregivers.
There has been substantial evidence which shows that advanced care planning positively
impacts quality of end-of-life, decreases use of life-sustaining treatment, and increases use of
hospice and palliative care while preventing unnecessary hospitalizations (BrinkmanStoppelenburg, 2014). Legally binding documents, such as advanced directives and advance care
planning, are tools which are to be used in order to give patients the death they have shown
preference for. Without these discussions and documents in place, there is no definitive answer
to what the patient’s preferences are when they are incapacitated and can no longer speak or
make decisions for themselves. Patients are more likely to receive end-of-life care that is
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consistent with their preferences when they have had the opportunity to discuss their wishes with
a physician (Mack, 2010). Care inconsistent with patient preferences can be associated with
numerous negative outcomes, including higher healthcare costs. Patients who have shown
preference for comfort care but believed that their care was inconsistent with their wishes had
higher medical care costs than those who believed that their care was consistent with their wishes
(Teno, 2002). Patients who receive care inconsistent with their wishes are not only experiencing
decreased quality of life at the end-of-life, but are also paying a high price for it.
Cost of Treatment
Patient-physician discussions about end-of-life allow for patients to set their boundaries
on which types of care they do and do not wish to receive. Patients who have these conversations
with physicians have been shown to have significantly lower health care costs as well as less
physical distress in their final week of life (Zhang, 2009). Patients at end-of-life represent a
disproportionate share of Medicare’s costs, and this number will continue to increase as the
number of Medicare beneficiaries increases with the aging population. Most notably, Medicare
expenditures increase sharply in the last few days of life, particularly for patients who die in the
hospital (Duncan, 2019). Palliative care services may help to ensure that care at the end-of-life is
consistent with patient and family goals while still reducing the cost of care. Increasing value of
care while minimizing costs in the care of seriously ill individuals is one of the major public
health challenges in America.
Higher costs of healthcare treatment are also associated with worse quality of death
(Zhang, 2009). The cost of aggressive measures at the end-of-life is not only monetary but is also
physically and psychologically taxing to the patient. Many individuals who pursue aggressive
measures at the end-of-life do so in hopes that it will extend their life, but studies have shown
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(Mack, 2010). Interestingly, this same study noted that poorer quality of life and increased
distress has been associated with life-extending treatments.
Palliative and Hospice Care
One in five Americans die using intensive care unit services (Agnus, 2005 & Dartmouth
Atlas of Healthcare, 2017). As the aging population continues to rise, is expected that this
number should only increase with time. In order to accommodate for a rapidly growing elderly
population, our health care system will be forced to expand intensive care units and staff or find
alternative ways to embrace and treat dying Americans. The highly technological critical care
environment of emergency rooms and intensive care units may press for more aggressive
treatments which could potentially prolong suffering of end-of-life patients.
Palliative care offers an approach which gives the highest possible quality of life while
still aiming for the longest possible life. Patients undergoing palliative care can still receive
treatments which could potentially cure their disease. Patients are able to participate in shared
decision making with their physicians and care team while still focusing on the qualities of life
which are important to them. Palliative care teams are multidisciplinary and often include
doctors, nurses, social workers, therapists, and chaplains who collectively come together to
provide medical, social, emotional, and practical support to the patient and their family. If the
care team no longer believes the patient is benefiting from continued treatment, they can be
transferred to hospice care.
Some of the shortcomings in the care of near-death patients and their families include
limited communication in regard to care plans, prognosis, and transfer to hospice care (Bradley,
2002). There is substantial evidence of increased patient and family satisfaction with hospice
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services, either at home or inpatient. Hospice care is an important approach to addressing
palliative care needs in those patients with a limited life expectancy. Admission requirements to
hospice care require a physician’s diagnosis of a terminal illness in which the patient has only six
months or less to live.
The hospice movement began with the work of Dr. Cicely Saunders, who opened St.
Christopher’s Hospice in London in 1967. As a nurse, social worker, and physician, she was
devoted to the dying and aimed to advance the modern hospice movement to focus on patientcentered care and pain management. Prior to her work, medicine was focused on curing disease
and those who could not be cured were a sign of failure. The first hospice program established in
the US was in 1974 and was based on the practice of St. Christopher’s Hospice. Since 1983,
hospice services have become widely available through Medicare, Medicaid, and almost all US
insurance plans. In 2016, there were 4,382 Medicare-certified hospices operating in the US
(Bhatnagar, 2021). As the access to palliative and hospice services continues to increase, the
opportunities to improve value in health care and quality of life at the end-of-life will continue to
increase.
Providing a good death would suggest patients would feel more comfortable with dying
at home. Initially as life expectancy increased a few decades ago, patients and families expressed
feeling overwhelmed about managing symptoms or a dead body in their home and showed
preference for skilled facilities (Steinhauser, 2000). However, more recent evidence shows
people prefer to die at home, even as their illness progresses (Gomes, 2018). Focusing on homebased care is important but also requires policy in place to support those who do not feel quality
of care and their quality of life is met with dying at home. Hospice benefits under Medicare fall
into four different categories: routine home care, continuous home care, general inpatient care,
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and respite care. Patients with more advanced disease who require a higher level of care can be
admitted into hospice homes, units at the hospital, or nursing homes where they receive 24/7
care. Patients can also decide to receive hospice cares at home and have regular daily to weekly
visits from nurses and other aids but also have 24/7 access to a nurse over the phone. When the
patient dies at home, the family is instructed to call a hospice nurse instead of 911.
Diagnosis of a fatal disease can be devastating but being able to provide these patients
and their families with comfort care tailored to their specific needs and wishes can potentially
improve the amount of suffering they endure. Hospice care is not focused around trying to cure
or fight their disease but rather on how an individual’s last moments of life can be enhanced by
the activities they enjoy, last wishes, being surrounded by family, and alleviating symptoms of
pain. Hospice care centers around social support and comfort measures which allows the patient
to live out the remainder of their life with close support but while still relieving pain and
managing symptoms of active death. Palliative and hospice care have become a growing field of
medicine but will likely require more public education in order for society to properly utilize
their services as the definition of a good death continues to evolve.
Education & Initiatives
In 1994, the Open Society of Institute (OSI) initiated a new program called the Project on
Death in America (PDIA) in hopes to improve the experience of dying in the United States. By
the end of 2003, PDIA had distributed $45 million in grant awards to various organizations and
individuals rooted in professional and public education, public policy, research, and clinical care,
all of which are strongly dedicated to improving end-of-life care for dying patients and their
families. The work of this organization did not stop because there was a lack of need but rather
there simply was not enough funding to keep up with their efforts to challenge end-of-life care.
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As the PDIA finished its movement in 2003, the International Observatory on End of Life
Care (IOELC) at Lancaster University, UK, was founded. This organization was the first ever to
provide clear and accessible research-based information about palliative and hospice care at the
international level (Clark, 2007). Since its establishment, the IOELC has conducted research on
the impact of various care settings, models of hospice and palliative care, populations receiving
hospice and palliative care, clinical research, and research methods related to improving end-oflife care.
It is also important to focus on the education of professionals in the medical field
regarding aging populations, palliative care, and hospice care. By properly educating and
influencing the attitudes of physicians, they can in turn influence the care of end-of-life patients
in order to guide them on deciding what a good death means to the individual and making these
preferences known. Proper physician education on advance care planning allows them to feel
comfortable to discuss these issues with patients and subsequently increases the number of endof-life decisions patients make. It is important to incorporate end-of-life care into medical
schools, residency programs, and continuing education for physicians that better cover the
complexity of caring for the dying population. Physicians who have more knowledge about
terminal care and hospice care have more discussions with their patients about hospice care and
refer their patients more often for such care. Greater knowledge about end-of-life care has also
been associated with a more positive attitude about terminal care and hospice care (Bradley,
2002). Major initiatives, such as Robert Wood Johnson Foundation’s Last Rites Campaign and
American Medical Association’s Education for Physicians on End-of-Life Care project, are
striving to improve the quality of end-of-life care by providing education for professionals and
the public. Many dying individuals have demonstrated desire to alleviate burden, which includes
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financial, on their family members and have expressed worry about the potential high costs of
aggressive care near end-of-life. Proper education of end-of-life care and options of quality
treatment could reduce unnecessary prolonged suffering and extortionate price.
Pandemic Considerations
The recent coronavirus (COVID-19) pandemic has shed an entirely different light on endof-care discussions between physicians, patients, and their family members. The quick spread of
disease has led to overrun critical care units with limited staff, beds, and equipment (Pattison,
2020), which has raised important ethical questions, specifically regarding the potential need to
ration cares provided based on likelihood of survival. Data has shown that coronavirus
disproportionately affects those who are elderly, frail, or with chronic health conditions because
they are at higher risk of both contracting COVID-19 and suffering a more severe disease course
(Yang, 2020). As infections continued to climb rapidly, many people became worried that a
healthier individual may receive a ventilator over them because their chances of survival or high
quality of life after aggressive care was small. Clinicians are given the duty to ensure that
patients receive the care that aligns with their goals and values, but the pandemic posed a
challenge because many individuals became very ill before they could complete advanced care
planning. This pandemic has highlighted the importance of advance care planning prior to
serious acute illness and clear discussions about goals of care at the onset of serious acute illness.
Clinicians should encourage these conversations in order to avoid intensive life-sustaining
treatments which could be unwanted by patients and can put other patients, family members, and
health care workers at higher risk of transmission of COVID-19 (Curtis, 2020). For patients
hospitalized with COVID-19, the focus for goals of treatment is typically establishing a code
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status, or the use of cardiopulmonary resuscitation (CPR) and advanced cardiac life support
(ACLS).
The pandemic has also caused a substantial restriction in visitors in the hospitals and
nursing homes. Due to physical distancing guidelines and travel restrictions, it may not be
possible to provide physical comfort to patients at the end-of-life. At the beginning of the
pandemic, elective surgeries were canceled for several months, medical appointments were
switched to phone and zoom calls, and patients who needed medical attention often deterred
seeking care in fear of contracting COVID-19. Those hospitalized with COVID-19 were not
allowed any visitors and those hospitalized for other reasons were often only allowed one visitor
which had to be the same person throughout the entire hospitalization. Many patients took their
last breaths alone in their hospital or nursing home rooms and most families did not have the
opportunity to say their goodbyes in person. Funeral homes and crematories have been
overwhelmed with a soaring demand for their services and traditional in-person funeral services
were mostly stopped with only the option to watch from home with live-streaming services. All
of these sudden changes have placed an enormous emotional and psychological burden on
individuals, care teams, and their families. Families bereaved as a result of their loved one dying
while under critical care have been shown to have worse outcomes (Lundorff, 2017), but we can
expect higher numbers of complicated grief to arise given the unusual circumstances of the
COVID-19 pandemic.
Conclusion
End-of-life care has evolved in the last several decades as people are living much longer
than they used to. As a result of longer life, individuals are developing chronic and progressive
diseases which have a remarkable impact on quality of life. Individuals with conditions such as
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chronic kidney disease, congestive heart failure, dementia, or various cancers are physically
unable to live the same life as individuals without these diseases, which can also have a profound
impact on their mental state. Although the field of medicine, specifically emergency medicine
and critical care medicine, have advanced significantly to be able to provide lifesaving
treatments in order to extend life but have brought up numerous ethical questions about
unnecessarily prolonging life. Once these patients are no longer able to physically heal,
aggressive and life prolonging measures become futile and focusing on comfort care and
improving quality of life in the final days is a more appropriate goal of treatment. Common
hopes of end-of-life care include avoiding suffering and having wishes respected as well as
followed.
Personal preferences for care are especially important when providing end-of-life care in
order to provide the best possible death. Each individual’s story is different at the end-of-life;
death can come suddenly, or a person can linger and gradually fade away. Some individuals
remain physically strong while cognition becomes impaired, and vice versa. Defining quality
care at the end-of-life is important but also differs for individuals based on a variety of factors
including age, culture, and life experiences. These factors can vary greatly when looking at the
diversity of individuals living in the United States. The healthcare system in the United States
has been challenged by these expectations from patients and their families and subsequently will
force the healthcare industry to further expand palliative and hospice services in order to provide
individuals with the death they deserve and support their families as they experience often
overwhelming grief.
Palliative and hospice care serve as options for individuals with chronic and progressive or
terminal diseases. The multidisciplinary teams of palliative care aim to offer the highest possible
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quality of life while still aiming for the longest possible life. Patients are able to participate in
shared decision making with their care team while still focusing on the qualities of life which are
important to them. If the patient is no longer benefiting from treatment, the transition to hospice
care is initiated. Hospice care focuses on emotional support and comfort measures which allows
the patient to live out the remainder of their life while relieving pain and managing symptoms of
active death.
The recent coronavirus (COVID-19) pandemic has brought to light how important endof-life discussions and advanced care planning truly is. Many individuals with chronic conditions
at baseline who were infected with SARS-CoV-2 became very ill quickly and were unable to
express their wishes for treatment and establish a code status. This pandemic has showed the
importance of advance care planning prior to serious acute illness as well as clear discussions
about goals of care at the onset of serious acute illness. Facing terminal illness and death is tough
for both patients and their families but creating adaptable treatment plans is necessary in order to
provide them with appropriate end-of-life care and a good death.
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